KING LUTHER CAPITAL MANAGEMENT CORP

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 310051 FORT WORTH, TX

Position in ARWR

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$3,368,557

-$646,378 QoQ

Shares Held

53,725

-11.2% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

KING LUTHER CAPITAL MANAGEMENT CORP holds $9,019,114 across 6 Biotechnology names. ARWR ranks #2 (37.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	66,584	$4,303,323
2	ARWR	Arrowhead Pharmaceuticals, Inc. This page	53,725	$3,368,557
3	REGN	Regeneron Pharmaceuticals, Inc.	948	$732,462
4	MNKD	Mannkind Corp	138,605	$339,582
5	ABSI	Absci Corp	77,520	$232,560
6	RANI	Rani Therapeutics Holdings, Inc.	58,000	$42,630

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,368,557	53,725	-11.2%	Shares	Sole	2026-05-11
2025-12-31	$4,014,935	60,475	-25.0%	Shares	Sole	2026-02-09
2025-09-30	$2,781,273	80,640	+54.7%	Shares	Sole	2025-11-07
2025-06-30	$823,812	52,140	-37.6%	Shares	Sole	2025-08-07
2025-03-31	$1,064,936	83,590	+8.6%	Shares	Sole	2025-05-12
2024-12-31	$1,446,942	76,965	-5.0%	Shares	Sole	2025-02-07
2021-06-30	$6,707,177	80,985	0.0%	Shares	Sole	2021-08-13
2021-03-31	$5,370,115	80,985	+16.3%	Shares	Sole	2021-05-12
2020-12-31	$5,341,558	69,615	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.